Select a community
All Communities
Home > Community Treatment Reports > Levodopa-Benserazide Treatment Report
What is Levodopa-Benserazide?

Levodopa is the precursor molecule to dopamine, an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide is an additive which allows the levodopa to continue circulating in the body for longer.

Side Effects

Side effects as an overall problem

Severe
1 13%
Moderate
2 25%
Mild
2 25%
None
3 38%

Most commonly reported side effects

tiredness
3 38%
Depression
2 25%
sickness
1 13%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Levodopa-Benserazide. See all 22 dosages ►

  25mg as needed 2 intl units daily 2 mg daily 3 mg daily 5 mg daily 25 mg daily 50 mg daily 62.5 mg daily 100 mg daily 125 mg daily 150 mg daily 187.5 mg daily 250 mg daily 300 mg daily 375 mg daily 400 mg daily 425 mg daily 500 mg daily 525 mg daily 600 mg daily 625 mg daily 750 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Levodopa-Benserazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
3 50% Other: 50%
Did not seem to work
1 17% Did not seem to work: 17%
Side effects too severe
1 17% Side effects too severe: 17%
Not indicated
1 17% Not indicated: 17%

See all 6 patients who’ve stopped taking Levodopa-Benserazide

Duration See details about how long patients take this treatment ▼

Currently Taking Levodopa-Benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
2
1
2
9

Stopped Taking Levodopa-Benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
2
2
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
7 88%
Usually
1 13%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 13%
Somewhat
1 13%
A little
2 25%
Not at all
4 50%

Cost

Paid out of pocket

$200+
1 13%
$100-199
0 0%
$50-99
1 13%
$25-49
0 0%
< $25
4 50%

Report created on November 21, 2009.